INFO@PRIMEEQUITYRESEARCHLLC.COM

orgenesis stock report


Orgenesis Inc Report


Orgenesis Inc. (ORGS) is a development stage company based in the USA, developing a novel method of treating diabetes using cell therapy to restore normal glucose-regulated insulin secretion. The technology is being researched and developed by the company’s Israeli arm Orgenesis Ltd. The new treatment methodology has seen encouraging results in pre-clinical studies both